Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019

Clin Infect Dis. 2023 May 24;76(10):1735-1737. doi: 10.1093/cid/ciad086.
No abstract available

Keywords: COVID-19; Tenofovir; confounding; drug repurposing; observational studies.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • COVID-19*
  • Emtricitabine / therapeutic use
  • HIV
  • HIV Infections* / virology
  • Humans
  • Tenofovir / therapeutic use
  • United States

Substances

  • Tenofovir
  • Emtricitabine
  • Anti-HIV Agents